Surgical video in life sciences and perioperative research

When might surgical footage be useful to a research team?

Video can help describe what was visible during a procedure, when a defined event occurred, or how a workflow unfolded. For a life sciences team, the useful starting point is an observational question that video can actually answer. Avoid collecting broad footage first and deciding later what scientific claim it might support.

For example, a team could explore whether a proposed event definition can be applied consistently by qualified reviewers. Another could study whether recording coverage is adequate for a future protocol. These are methodological questions; they do not by themselves demonstrate a treatment effect.

Document which measurements come directly from video, which come from a separate record, and which are derived by a model. Mixing these sources without a clear lineage makes later interpretation difficult.

Is clinical or outcome information included with the video?

Do not assume so. A video license may contain no linked treatment, pathology, follow-up, or outcome data. If the question requires those variables, scope them explicitly with the appropriate data holders and review teams. The feasibility of linkage may determine whether the study can proceed.

Use the minimum information appropriate to the approved purpose. An initial supplier conversation can describe required variables without transmitting actual patient records.

How should teams distinguish exploration from evidence?

An exploratory analysis can reveal whether a signal is worth studying, but the design may not support a causal interpretation. Case selection, recording practices, treatment differences, and missing follow-up can all affect what an apparent relationship means. Define the analysis with the relevant methodological experts.

FDA’s FDA: AI and machine learning in drug development includes joint FDA–EMA guiding principles issued in January 2026. Regulatory use of AI is a distinct consideration from finding a technically interesting pattern. A dataset supplier should not imply that access to footage makes an endpoint valid or an analysis acceptable for a specific submission.

Decide in advance how exploratory findings will be labeled, what follow-up work they would motivate, and which claims remain outside the project.

What should clinician annotation contribute?

Clinicians can help assess whether the proposed concept is observable and whether different reviewers apply it consistently. They can identify moments when the view is inadequate, context is missing, or a label would require information beyond the recording.

• Define the observable event and its boundaries.
• Distinguish absent events from events that cannot be assessed.
• Provide a process for uncertain or disputed examples.
• Keep video-based judgments separate from linked-record information where the protocol requires it.
• Version the guide and document any changes during the study.

If experts are shown outcome information during annotation, consider whether that could influence their interpretation. The appropriate blinding and review process depends on the study design and should be specified by the research team.

What should a life sciences data brief contain?

Describe the scientific question, procedure family, required visual coverage, proposed annotations, and any separately needed clinical variables. Include the study stage, intended recipients, geographic scope, and anticipated use of the findings. This gives a potential partner enough context to assess feasibility.

Operavue welcomes research discussions with life sciences and pharmaceutical teams. Surgical video, expert interpretation, and any linked information are distinct deliverables whose availability and permissions must be established. Start with a non-confidential buyer inquiry; do not include patient data in the public form.